Cat.#: ACPP-1238
| Despition | LIMK1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1540 | Mouse IL-6 Protein, His (AC1540) | 5 µg | inquiry |
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1112 | Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) | 50 µg | inquiry |
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1804 | Human STMN2 Protein (AC1804) | 2 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
| ACPP-1411 | Human NDEL1 Protein (AC1411) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.